Literature DB >> 7628566

Plasmodium falciparum: variations within the C-terminal region of merozoite surface antigen-1.

R Tolle1, H Bujard, J A Cooper.   

Abstract

Sequence variations at the 3'-end of the Plasmodium falciparum merozoite surface antigen-1 gene show that the C-terminus of the protein may not be as conserved as has been assumed in the past. We have therefore examined the sequences of the 3' terminal 2 kb, i.e., blocks 12-17 of four isolates, RO-33, RO-71, 3D7A, and FCH5. We discuss different mechanisms of genetic exchange that could account for the observed variations. Furthermore the deduced amino acid sequences allow us to identify allelic epitopes of three monoclonal antibodies. Finally, our data complete the sequence of two additional independent alleles of this gene (RO-33 and RO-71).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7628566     DOI: 10.1006/expr.1995.1091

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  8 in total

1.  Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum.

Authors:  A A Escalante; A A Lal; F J Ayala
Journal:  Genetics       Date:  1998-05       Impact factor: 4.562

2.  A comparative study of the genetic diversity of the 42kDa fragment of the merozoite surface protein 1 in Plasmodium falciparum and P. vivax.

Authors:  M Andreina Pacheco; Amanda C Poe; William E Collins; Altaf A Lal; Kazuyuki Tanabe; Simon K Kariuki; Venkatachalam Udhayakumar; Ananias A Escalante
Journal:  Infect Genet Evol       Date:  2006-09-28       Impact factor: 3.342

3.  Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial.

Authors:  A W Stowers; V Cioce; R L Shimp; M Lawson; G Hui; O Muratova; D C Kaslow; R Robinson; C A Long; L H Miller
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

4.  Regulated maturation of malaria merozoite surface protein-1 is essential for parasite growth.

Authors:  Matthew A Child; Christian Epp; Hermann Bujard; Michael J Blackman
Journal:  Mol Microbiol       Date:  2010-02-08       Impact factor: 3.501

5.  Malaria vaccine-related benefits of a single protein comprising Plasmodium falciparum apical membrane antigen 1 domains I and II fused to a modified form of the 19-kilodalton C-terminal fragment of merozoite surface protein 1.

Authors:  Bart W Faber; Edmond J Remarque; William D Morgan; Clemens H M Kocken; Anthony A Holder; Alan W Thomas
Journal:  Infect Immun       Date:  2007-10-15       Impact factor: 3.441

6.  Safety and immunogenicity of multi-antigen AMA1-based vaccines formulated with CoVaccine HT™ and Montanide ISA 51 in rhesus macaques.

Authors:  Kwadwo A Kusi; Edmond J Remarque; Vanessa Riasat; Vanessa Walraven; Alan W Thomas; Bart W Faber; Clemens H M Kocken
Journal:  Malar J       Date:  2011-07-04       Impact factor: 2.979

7.  Merozoite surface protein 4/5 provides protection against lethal challenge with a heterologous malaria parasite strain.

Authors:  M W Goschnick; C G Black; L Kedzierski; A A Holder; R L Coppel
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

8.  Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge.

Authors:  L Rénia; I T Ling; M Marussig; F Miltgen; A A Holder; D Mazier
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.